Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Wave Life plans a 2026 NDA filing for WVE-N531 after positive Phase 2 data in Duchenne muscular dystrophy, showing functional gains and biomarker improvements.

Gannon University and Saint Vincent Hospital announced plans Wednesday to develop two new laboratories inside Gannon's ...

Wave Life Sciences (WVE) stock rises on plans to file for FDA accelerated approval of WVE-N531 in 2026, targeting Duchenne muscular dystrophy. Read more here.

The molecule was found in soil samples collected from a laboratory technician’s garden. The discovery shows that “there is ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...

Oncogenic proteins are essential for the development and spread of tumors, making cancer a significant worldwide health ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

Weissman was jointly awarded the 2023 Nobel Prize in Medicine with Katalin Karikó for discoveries which made COVID-19 ...